EU Wants Industry To Define ‘Trade Secrets’ Under Health Data Sharing Regulation

The European Health Data Space Regulation is deliberately “vague” when it comes to defining trade secrets because the EU wants the pharma industry to make recommendations on safeguarding intellectual property, a policy officer for the European Commission says.

The European Health Data Space is vague “by design” on trade secrets to allow industry to shape its implementation (Shutterstock)

More from Legal & IP

More from Legislation